All risk factors—including MELD score, pretransplant treatment, AFP level, tumor count, largest tumor size, macrovascular invasion, tumor differentiation, graft CIT, intraoperative allogeneic blood transfusion, and intraoperative autologous blood transfusion—were adjusted. The gene discussed is AFP; the disease is neoplasm.